心不全におけるポリファーマシーに関連した心血管リスク:体系的なレビューとメタ解析
Jane J Lee1, Minseo Kim1, Gerald Chi2
1Department of Food and Nutrition, Sookmyung Women's University, Seoul, Republic of Korea.
ESC heart failure
|February 19, 2026
まとめ
多剤療法,つまり複数の薬剤の使用は,HF患者における有害な心血管疾患 (CV) のリスクと心不全 (HF) の入院リスクを高めます. 治療と患者のアウトカムを最適化するために,注意深く医薬品のレビューを行うことが不可欠です.
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
- 公衆衛生は公衆衛生である.
背景:
- 多剤薬は,複数の併発性疾患とガイドラインに基づく治療により,心不全 (HF) 患者において一般的です.
- 治療の最適化を目的としているが,ポリファーマシーは薬物相互作用や有害事象につながる可能性がある.
- HF集団における心血管 (CV) のアウトカムに対するポリファーマシーの影響に関する証拠は限られている.
研究 の 目的:
- ポリファーマシーとHF患者における不良CVアウトカムとの関連を調査する.
- このコホートにおけるポリファーマシーに関連した特定のCVイベントのリスクを定量化するために.
主な方法:
- システマティック・レビューとメタ解析が行われました.
- 関連する研究を特定するために,PubMed,Embase,Web of Scienceで検索が行われました.
- ランダム効果モデルを使用して,最も高いレベルと最も低いレベルのポリファーマシーを比較した効果推定をまとめました.
主要な成果:
- この分析には,30,115人のHF患者を含む10件の研究が含まれる.
- 複製薬は,複合CVエンドポイント (HR: 1.27; 95%CI: 1.15-1.39) のリスクを有意に増加させた.
- ポリファーマシー (HR: 1.42; 95% CI: 1.28-1.56) を服用した患者では,HF入院のリスクが高かったが,CVによる死亡や全原因による死亡率と有意な関連性は認められなかった.
結論:
- HF患者のポリファーマは,複合CVアウトカムとHF入院のリスクの増加と関連しています.
- これらの発見は,HF患者の複数の薬剤の管理における課題を強調しています.
- 個別化された医薬品レビューは,不適切な処方を減らすために,そしてエビデンスベースのケアを確保するために極めて重要です.
関連する概念動画
01:30Heart Failure V: Medical Management
388
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
388
01:29Cardiomyopathy V: Interprofessional Care
501
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
501
01:24Drug Toxicity: Risk factors
33
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
33
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
01:15Drug Dosing: Geriatric Patients
306
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
306
01:22Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K